Itraconazolo Mylan Generics

Itraconazole, the active ingredient in Itraconazolo Mylan Generics, is an azole antifungal presented as an oral dosage form for oral use. It treats a range of superficial and systemic fungal infections in adults, adolescents and children as prescribed under medical supervision.

GNH USA supplies Itraconazolo Mylan Generics as a licensed, GDP‑compliant international pharmaceutical supplier, providing reliable bulk shipments to hospitals, pharmacies, and clinics across Europe, Asia, Africa and the Americas, ensuring regulatory compliance and product quality for global healthcare providers.

Itraconazole is used to treat fungal infections affecting the skin, nails, and internal organs.

Dermatophytosis: resolves skin ringworm infections by eradicating the causative dermatophytes. Onychomycosis: eliminates fungal infection of the nails, promoting regrowth of healthy nail tissue. Blastomycosis: treats systemic blastomyces infection by inhibiting fungal growth. Histoplasmosis: clears histoplasma organisms in pulmonary and disseminated disease. Coccidioidomycosis: combats coccidioides infection in lungs and extrapulmonary sites. Aspergillosis: manages invasive aspergillus infections, especially in immunocompromised patients.

Itraconazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset. - Vomiting: occasional episodes. - Abdominal pain: cramping discomfort. - Rash: skin irritation or redness.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiac failure: new or worsening heart failure symptoms.

When prescribing itraconazole, clinicians should consider several safety measures. - Liver function monitoring: obtain baseline tests and repeat periodically. - Drug interaction review: assess concomitant medications for CYP3A4 effects. - Cardiac status assessment: avoid in patients with existing heart failure. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at ambient temperature: keep in original container, protect from moisture and light.

Itraconazole interacts with several medicines that can alter its effectiveness or increase toxicity.

Major Interactions (Avoid): - Rifampin: markedly reduces itraconazole plasma concentrations. - Ketoconazole: additive hepatotoxic risk when combined. - St. John’s wort: induces metabolism leading to loss of efficacy.

Moderate Interactions (Monitor Closely): - Erythromycin and other CYP3A4 inhibitors: may increase itraconazole levels, monitor for toxicity. - Statins metabolized by CYP3A4: risk of myopathy, adjust dose or monitor. - Warfarin: potential increase in anticoagulant effect, monitor INR.